“AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System - Taiwan Registration 7d3cfbe36f2bad13c0ada5bf2ad70fbc
Access comprehensive regulatory information for “AtriCure” AtriClip Gillinov-Cosgrove LAA Exclusion System in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 7d3cfbe36f2bad13c0ada5bf2ad70fbc and manufactured by Atricure, Inc.. The authorized representative in Taiwan is ASIA HEALTH CARE CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
7d3cfbe36f2bad13c0ada5bf2ad70fbc
Ministry of Health Medical Device Import No. 034494
DHA05603449403
Product Details
For details, it is Chinese approved copy of the imitation order
E Cardiovascular devices
E9999 Other
Imported from abroad
Dates and Status
Apr 09, 2021
Apr 09, 2026

